Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,221 | 879 | 96.8% |
| Education | $433.84 | 6 | 2.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $97.35 | 7 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $1,348 | 72 | $0 (2024) |
| UCB, Inc. | $1,275 | 59 | $0 (2024) |
| ABBVIE INC. | $1,214 | 70 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $996.22 | 65 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $874.14 | 29 | $0 (2024) |
| EMD Serono, Inc. | $735.55 | 50 | $0 (2024) |
| GENZYME CORPORATION | $689.13 | 32 | $0 (2024) |
| Genentech USA, Inc. | $620.59 | 38 | $0 (2024) |
| SK Life Science, Inc. | $498.90 | 18 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $487.39 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,395 | 145 | Alexion Pharmaceuticals, Inc. ($442.47) |
| 2023 | $2,922 | 141 | AbbVie Inc. ($425.91) |
| 2022 | $2,809 | 137 | ABBVIE INC. ($308.21) |
| 2021 | $1,580 | 93 | Novartis Pharmaceuticals Corporation ($177.48) |
| 2020 | $686.26 | 37 | Novartis Pharmaceuticals Corporation ($133.95) |
| 2019 | $2,003 | 125 | Novartis Pharmaceuticals Corporation ($276.82) |
| 2018 | $1,497 | 92 | UCB, Inc. ($138.93) |
| 2017 | $1,861 | 122 | Teva Pharmaceuticals USA, Inc. ($209.29) |
All Payment Transactions
892 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Musculoskeletal | ||||||
| 12/11/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/04/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: PAIN | ||||||
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: AMANTADINE | ||||||
| 12/03/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Neuroscience | ||||||
| 12/02/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.33 | General |
| 11/27/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Neurology | ||||||
| 11/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Immunology | ||||||
| 11/19/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: EPILEPSY | ||||||
| 11/06/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $32.49 | General |
| 11/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Central Nervous System | ||||||
| 11/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: AMANTADINE | ||||||
| 10/31/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Adenosine A2A Receptors | ||||||
| 10/29/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Neurology | ||||||
| 10/28/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Neurology | ||||||
| 10/16/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: Neurology | ||||||
| 10/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Immunology and Neurology | ||||||
| 10/08/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 706 | 752 | $179,951 | $63,534 |
| 2022 | 16 | 731 | 6,349 | $266,739 | $85,398 |
| 2021 | 13 | 642 | 697 | $141,624 | $51,907 |
| 2020 | 14 | 661 | 4,465 | $211,824 | $65,833 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 174 | 174 | $61,944 | $20,869 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 104 | $24,024 | $9,230 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 107 | $16,799 | $6,833 | 40.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 43 | $18,318 | $5,704 | 31.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 47 | $13,630 | $4,788 | 35.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $11,466 | $3,641 | 31.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 61 | 72 | $6,120 | $2,757 | 45.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 41 | 42 | $8,946 | $2,726 | 30.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 16 | $7,584 | $2,668 | 35.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 28 | $4,284 | $1,735 | 40.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 40 | 41 | $3,936 | $1,715 | 43.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 27 | 29 | $2,900 | $866.52 | 29.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 12 | 5,575 | $94,775 | $24,556 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 129 | 129 | $45,924 | $16,263 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 108 | $16,956 | $7,079 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 60 | $13,860 | $5,681 | 41.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 72 | 72 | $15,336 | $5,676 | 37.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 46 | 46 | $13,340 | $4,803 | 36.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 27 | $11,502 | $4,145 | 36.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 45 | 45 | $10,530 | $3,699 | 35.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 12 | 30 | $14,580 | $3,043 | 20.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 74 | 84 | $7,140 | $2,583 | 36.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 55 | 58 | $5,568 | $2,314 | 41.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 26 | $3,978 | $1,475 | 37.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 21 | 21 | $3,402 | $1,172 | 34.4% |
About Dr. Dreama Brar, M.D
Dr. Dreama Brar, M.D is a Neurology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730386459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dreama Brar, M.D has received a total of $16,752 in payments from pharmaceutical and medical device companies, with $3,395 received in 2024. These payments were reported across 892 transactions from 84 companies. The most common payment nature is "Food and Beverage" ($16,221).
As a Medicare-enrolled provider, Brar has provided services to 2,740 Medicare beneficiaries, totaling 12,263 services with total Medicare billing of $266,672. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Richmond, VA
- Active Since 06/27/2007
- Last Updated 04/23/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730386459
Products in Payments
- Briviact (Drug) $818.95
- TYSABRI (Biological) $709.64
- ULTOMIRIS (Biological) $579.41
- QULIPTA (Drug) $566.00
- AUBAGIO (Drug) $432.39
- OCREVUS (Biological) $400.08
- KESIMPTA (Drug) $369.75
- APTIOM (Drug) $299.26
- Gamunex-C (Biological) $297.89
- ACTHAR (Biological) $288.43
- NURTEC ODT (Drug) $283.10
- EMGALITY (Drug) $277.03
- Rebif (Biological) $266.41
- VALTOCO (Drug) $261.15
- RYTARY (Drug) $251.85
- EPIDIOLEX (Drug) $244.55
- Aimovig (Biological) $234.80
- BOTOX (Biological) $234.50
- DUOPA (Drug) $233.52
- Hizentra (Biological) $227.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Richmond
Catherine Ham, Md, MD
Neurology — Payments: $551,939
Dr. Daniel Hardy, M.d, M.D
Neurology — Payments: $360,216
Myla Goldman, Md, MD
Neurology — Payments: $211,301
Dr. Alan Schulman, M.d, M.D
Neurology — Payments: $171,196
Dr. Warren Felton, M.d, M.D
Neurology — Payments: $108,879
Dr. Matthew Boyce, M.d, M.D
Neurology — Payments: $103,206